[go: up one dir, main page]

NO984878D0 - Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters - Google Patents

Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters

Info

Publication number
NO984878D0
NO984878D0 NO984878A NO984878A NO984878D0 NO 984878 D0 NO984878 D0 NO 984878D0 NO 984878 A NO984878 A NO 984878A NO 984878 A NO984878 A NO 984878A NO 984878 D0 NO984878 D0 NO 984878D0
Authority
NO
Norway
Prior art keywords
amesters
alkoxypyridine
medicines
preparation
carboxylic acid
Prior art date
Application number
NO984878A
Other languages
Norwegian (no)
Other versions
NO984878L (en
Inventor
Klaus Weidmann
Karl-Heinz Baringhaus
Georg Tschank
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO984878D0 publication Critical patent/NO984878D0/en
Publication of NO984878L publication Critical patent/NO984878L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO984878A 1996-04-30 1998-10-19 Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters NO984878L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/001793 WO1997041103A1 (en) 1996-04-30 1996-04-30 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs

Publications (2)

Publication Number Publication Date
NO984878D0 true NO984878D0 (en) 1998-10-19
NO984878L NO984878L (en) 1998-12-29

Family

ID=8166212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984878A NO984878L (en) 1996-04-30 1998-10-19 Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters

Country Status (7)

Country Link
EP (1) EP0900202A1 (en)
JP (1) JP2000509047A (en)
KR (1) KR20000065090A (en)
AU (1) AU5762896A (en)
CA (1) CA2253282A1 (en)
NO (1) NO984878L (en)
WO (1) WO1997041103A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803592A1 (en) * 2000-01-06 2001-07-13 Aventis Cropscience Sa NOVEL DERIVATIVES OF 3-HYDROXYPICOLINIC ACID, PROCESS FOR THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS CONTAINING SAME
JP4590157B2 (en) 2001-03-21 2010-12-01 アイシス イノヴェイション リミテッド Assays, methods and means
WO2003053997A2 (en) * 2001-12-06 2003-07-03 Fibrogen, Inc. Methods of increasing endogenous erythropoietin (epo)
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
NZ601731A (en) 2006-06-26 2014-04-30 Akebia Therapeutics Inc Prolyl hydroxylase inhibitors and methods for use
IN2012DN04940A (en) 2009-11-06 2015-09-25 Aerpio Therapeutics Inc
EP2717870B1 (en) 2011-06-06 2017-09-27 Akebia Therapeutics Inc. Composition for stabilizing hypoxia inducible factor-2 alpha useful for treating cancer
NO2686520T3 (en) 2011-06-06 2018-03-17
WO2014105842A1 (en) 2012-12-28 2014-07-03 Dow Agrosciences Llc Synergistic fungicidal mixtures for fungal control in cereals
MX378150B (en) 2013-06-13 2025-03-10 Akebia Therapeutics Inc COMPOSITIONS AND METHODS FOR TREATING ANEMIA.
KR102381295B1 (en) 2013-11-15 2022-03-31 아케비아 테라퓨틱스 인코포레이티드 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
KR20170100619A (en) 2014-12-30 2017-09-04 다우 아그로사이언시즈 엘엘씨 Picolinamide as a fungicide
JP2018504389A (en) * 2014-12-30 2018-02-15 ダウ アグロサイエンシィズ エルエルシー Picolinamide with fungicidal activity
CN107207414B (en) 2014-12-30 2021-03-30 美国陶氏益农公司 Pyridinamide compounds with fungicidal activity
WO2016109303A1 (en) 2014-12-30 2016-07-07 Dow Agrosciences Llc Use of picolinamide compounds with fungicidal activity
CA2972413A1 (en) 2014-12-30 2016-07-07 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
BR112017015852A2 (en) 2015-01-23 2018-03-27 Akebia Therapeutics Inc crystal form, hemichalic salt, hemicalic salt dihydrate, hydrous monosodium salt, monohydrate bisodium salt, anhydrous monosodium salt and method for preparing compound 1
CR20210248A (en) 2015-04-01 2021-06-01 Akebia Therapeutics Inc Compositions and methods for treating anemia
JP6814134B2 (en) * 2015-05-28 2021-01-13 日本たばこ産業株式会社 How to treat or prevent diabetic nephropathy
TW201842851A (en) 2017-05-02 2018-12-16 美商陶氏農業科學公司 Synergistic mixture for fungal control in cereals
CN110996665B (en) 2017-05-02 2021-10-26 陶氏益农公司 Use of acyclic picolinamides as fungicides against fungal diseases on turfgrass
TWI774761B (en) 2017-05-02 2022-08-21 美商科迪華農業科技有限責任公司 Synergistic mixtures for fungal control in cereals
BR102019004480B1 (en) 2018-03-08 2023-03-28 Dow Agrosciences Llc PICOLINAMIDES AS FUNGICIDES
CN112088155A (en) 2018-05-09 2020-12-15 阿克比治疗有限公司 Process for the preparation of 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
EP3866597A4 (en) 2018-10-15 2022-06-29 Corteva Agriscience LLC Methods for sythesis of oxypicolinamides
US12281076B2 (en) 2019-10-18 2025-04-22 Corteva Agriscience Llc Process for synthesis of picolinamides
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101420T3 (en) * 1993-11-02 1997-07-01 Hoechst Ag ESTERS-AMIDES OF SUBSTITUTED HETERO-CYCLIC CARBOXYL ACIDS, THEIR PREPARATION AND THEIR USE AS MEDICINES.

Also Published As

Publication number Publication date
WO1997041103A1 (en) 1997-11-06
JP2000509047A (en) 2000-07-18
EP0900202A1 (en) 1999-03-10
AU5762896A (en) 1997-11-19
KR20000065090A (en) 2000-11-06
NO984878L (en) 1998-12-29
CA2253282A1 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
NO984878D0 (en) Preparation and Use as Medicines of 3-Alkoxypyridine-2-Carboxylic Acid Amesters
FI964920A7 (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical preparations containing them
FI973278A7 (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical preparations containing them
NO306253B1 (en) Arylsulfonyl hydroxamic acid derivatives, their use and pharmaceutical preparation
NO995137L (en) Preparation of Highly Active Catalysts; the catalysts and their use
NO961006L (en) Phosphonomononucleic acids, processes for their preparation and use of the compounds
DE19681287T1 (en) Oral formulation of 2-methylthienobenzodiazepine
BR9500784A (en) Compound and pharmaceutical formulation
BR9504060A (en) Compound and pharmaceutical formulation
FI972555L (en) Preparation of coated tablets
IS5245A (en) Pharmaceutical preparation of omeprazole
NO993868D0 (en) 3-piperidyl-4-oxoquinazoline derivatives and medical preparations containing them
NO20000294L (en) Derivatives of acylpiperazinylpyrimidines, their preparation and use as pharmaceuticals
NO971811D0 (en) Bicyclic tetrahydropyrazolopyridines and their use as drugs
NO953367L (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs
AR016694A1 (en) PROCEDURE FOR THE PREPARATION OF ACID DERIVATIVES 8-METOXI-3-CHINOLONCARBOXYLICS AND PURIFICATION PROCEDURE.
DE59711379D1 (en) ORAL APPLICABLE FORMULATIONS OF CHINOLONIC OR NAPHTHYRIDONE CARBONIC ACIDS
NO307510B1 (en) Bicyclic aromatic compounds, their use and pharmaceutical and cosmetic preparations thereof
NO991613D0 (en) Pharmaceutical microspheres of valproic acid for oral administration
EE200000226A (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
EE9900034A (en) Arylcycloalkanecarboxylic esters, their use, pharmaceutical compositions and their preparation
FI953887L (en) Pharmaceutical formulations of cefaclor
NO20001717D0 (en) Serotonin-containing formulation for oral administration and use of the same
DE69623593D1 (en) SOLIDS CONTAINING VALPROINIC ACID AND SODIUM VALPROAT
EE9800075A (en) Combined medicinal product, its use and method of its preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application